Silicon Laboratories (NASDAQ:SLAB – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of -0.190-0.010 for the period, compared to the consensus estimate of -0.080. The company issued revenue guidance of $170.0 million-$185.0 million, compared to the consensus revenue estimate of $175.6 million.
Analyst Upgrades and Downgrades
SLAB has been the subject of several research reports. Stifel Nicolaus lifted their price objective on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Susquehanna began coverage on Silicon Laboratories in a research report on Tuesday, December 17th. They issued a “neutral” rating and a $130.00 price objective on the stock. JPMorgan Chase & Co. dropped their price objective on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research report on Tuesday, November 5th. StockNews.com raised shares of Silicon Laboratories to a “sell” rating in a research note on Friday, November 8th. Finally, Benchmark reaffirmed a “hold” rating on shares of Silicon Laboratories in a research note on Tuesday, November 5th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $133.56.
Get Our Latest Stock Report on SLAB
Silicon Laboratories Stock Down 1.3 %
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.07. The firm had revenue of $166.00 million for the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The firm’s revenue was down 18.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.48 EPS. As a group, sell-side analysts expect that Silicon Laboratories will post -3.56 earnings per share for the current fiscal year.
Insider Buying and Selling at Silicon Laboratories
In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the sale, the director now owns 32,115 shares of the company’s stock, valued at $4,520,828.55. The trade was a 5.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.72% of the stock is currently owned by insiders.
Silicon Laboratories Company Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading
- Five stocks we like better than Silicon Laboratories
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- Russell 2000 Index, How Investors Use it For Profitable Trading
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.